RxDoctor Payments DataLook up a doctor →

Richard Haydel, MD

Family Medicine · Houma, LANPI 1578658555

Payments from drug & device makers

$15,238in general payments, 2019–2025

Across 1,002 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • GSK$1K
  • Pfizer$1K
  • Boehringer Ingelheim$975
  • Lilly USA, LLC$852
  • Amgen$830
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$15,187100%
  • Education$500%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)194$2,789
GSK102$1,350
Pfizer76$1,145
Boehringer Ingelheim61$975
Lilly USA, LLC69$852
Amgen46$830
Novo Nordisk50$738
AstraZeneca26$678
Merck35$464
Johnson & Johnson30$414
Kowa Pharmaceuticals America, Inc.27$380
Amarin Pharma, Inc.26$339
Antares Pharma, Inc.15$294
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC19$276
Astellas Pharma US Inc18$265
Sunovion Pharmaceuticals Inc.16$247
Esperion Therapeutics, Inc.14$213
Sanofi-aventis U.S. LLC13$198
Exact Sciences10$186
Jazz Pharmaceuticals Inc.8$173
Takeda Pharmaceuticals U.S.A., Inc.9$170
Mylan Specialty L.p.12$163
Bayer10$158
Vanda Pharmaceuticals Inc.7$146
Otsuka America Pharmaceutical, Inc.8$137
Eisai Inc.8$130
E.r. Squibb & Sons, L.L.C.8$112
Abbott5$94
Phathom Pharmaceuticals, Inc.6$92
Halozyme Inc4$87
Supernus Pharmaceuticals, Inc.5$77
Smith+Nephew5$75
Atland Pharmaceuticals, LLC1$71
Lundbeck LLC4$70
Daiichi Sankyo Inc.4$68
Teva Pharmaceuticals USA, Inc.5$65
Corium, LLC4$60
Seqirus USA Inc3$51
Arbor Pharmaceuticals, Inc.3$40
Azurity Pharmaceuticals, Inc.2$38
Biohaven Pharmaceuticals, Inc.2$37
Ironshore Pharmaceuticals Inc.2$34
Gilead2$30
Biohaven Pharmaceutical Holding Company Ltd.2$30
Sumitomo Pharma America, Inc.2$30
Hikma Pharmaceuticals USA2$30
Novartis2$28
Shire North American Group Inc2$27
Boston Scientific2$27
Tactile Systems Technology Inc2$26
Bausch Health US, LLC1$21
Optinose US, Inc.1$21
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$20
Viatris Specialty LLC1$20
Shield Therapeutics Inc1$18
Inspire Medical Systems, Inc.1$16
Dexcom, Inc.1$16
Radius Health, Inc.1$16
Tolmar, Inc.1$14
Clarus Therapeutics Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,238 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$355,400
Medicare patients
491
Services billed
25,726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide187$202,668
JardianceEmpagliflozin88$73,387
EliquisApixaban90$60,291
Trelegy ElliptaFluticasone/Umeclidin/Vilanter84$54,530
OzempicSemaglutide57$53,000
TrulicityDulaglutide36$42,075
TradjentaLinagliptin45$37,465
XareltoRivaroxaban44$29,870
LinzessLinaclotide44$26,692
JanuviaSitagliptin Phosphate39$21,720
MyrbetriqMirabegron22$20,427
OxycontinOxycodone Hcl17$16,762
Tresiba Flextouch U-200Insulin Degludec18$15,505
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen605$15,449
QuliptaAtogepant12$15,261

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$852$244,744223 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Spiriva Respimat, Jentadueto$975$139,254181 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$1,350$70,616113 claims
PfizerEliquis$1,145$60,29190 claims
Novo NordiskOzempic$738$53,00057 claims
AbbVieLinzess, Qulipta, Synthroid$2,789$46,097112 claims
MerckJanuvia, Janumet$464$32,80056 claims
Johnson & JohnsonXarelto$414$29,87044 claims
Astellas Pharma US IncMyrbetriq$265$20,42722 claims
AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort$678$18,40542 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$170$9,02218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Houma

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →